genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Antibiotic Resistance Mechanism Shows Achilles’ Heel
Financing
Benchtop Genome Engineering Platform Developer Inscripta Raises $125M in Series D…
News
Human Genes 10% More Numerous, If You Count smORFs
News
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Extracellular Matrix
Mapping Single-Cell pH Levels Could Hold Key to Improved Cancer Treatments
Insights
Bioprocessing
Insect Pupae May Transform Protein Production
Bioprocessing
Optimizing Biotherapeutic Onboarding
December 2019 Vol. 39 No. 12
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
December 2019 Vol. 39 No. 12
For Whom the Perturbed Cell Signaling Pathway Tolls
December 2019 Vol. 39 No. 12
Metabolomics Technology Navigates Oceans of Data
A-Lists
Cancer
Top 10 Immuno-Oncology Startups of 2019
Drug Discovery
Top 10 Pharma Companies of 2019
December 2019 Vol. 39 No. 12
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Antibiotic Resistance Mechanism Shows Achilles’ Heel
Financing
Benchtop Genome Engineering Platform Developer Inscripta Raises $125M in Series D…
News
Human Genes 10% More Numerous, If You Count smORFs
News
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Magazine
All
Supplement
December 2019 Vol. 39 No. 12
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
December 2019 Vol. 39 No. 12
For Whom the Perturbed Cell Signaling Pathway Tolls
December 2019 Vol. 39 No. 12
Metabolomics Technology Navigates Oceans of Data
December 2019 Vol. 39 No. 12
Taking Cell Lines to the Bank
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
The Dynamic Microbiome
December 2019 Vol. 39 No. 12
Understanding and Overcoming the Immune Response from Synthetic mRNAs
December 2019 Vol. 39 No. 12
Accelerating AAV to the Clinic with Purification Improvements
December 2019 Vol. 39 No. 12
Evaluation of a Small-Scale Perfusion Mimic for Intensified Processes
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Tech Exclusives
Tech Exclusives
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Tech Exclusives
Forces Unite to Move Molecular Dx Out of the Gates
Tech Exclusives
Tea for Type 2: Green Tea Triggers Gene Editing System for Diabetes Treatment
Tech Exclusives
Genome Editing Heads to Primetime
Tech Exclusives
GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing
Tech Exclusives
Blood Test to Diagnose Brain Cancer in Development
Tech Exclusives
Tocagen Axing 65% of Staff after Cancer Immunotherapy Combination Fails Phase...
Tech Exclusives
One-Stop-Shop Genome Editing Product Launched by Inscripta
Tech Exclusives
Modular Bioprocessing Makes Adaptability a Snap
Tech Exclusives
A Nanomedicine Technology Sampler Pack
Tech Exclusives
Beam Therapeutics Files for IPO, Pursuing Treatments Using Base Editing
Tech Exclusives
MicroRNA Biomarkers Make Melanoma Diagnosis More Objective
Tech Exclusives
Molecular Analysis of Elephantiasis Post-Treatment Adverse Events
Tech Exclusives
Long Reads and CRISPR Couple as Oxford Nanopore and Caribou Strike...
Tech Exclusives
Fungal-Derived Drugs Have Unexpected “Reaction”
Tech Exclusives
Continuous Manufacturing of Viral Vaccines
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Firm had previously rejected Astellas’ unsolicited bid of roughly $3.5 billion. [© Yuri Arcurs - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/May17_2010_495175_HandshakeBirdsEyeView_AstellasBuysOSI7721122207-2.jpg "Forces Unite to Move Molecular Dx Out of the Gates")
